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Abstract
Biomedical engineering is clearly present in modern neuroendocrinology, and indeed
has come to embrace it in many respects. First, we briefly review the origins of
endocrinology until neuroendocrinology, after a long saga, was established in the
1950’s decade with quantified results made possible by the radioimmunoassay tech-
nique (RIA), a development contributed by the physical sciences. However, instru-
mentation was only one face of the quantification process, for mathematical models
aiding in the study of negative feedback loops, first rather shyly and now at a grow-
ing rate, became means building the edifice of mathematical neuroendocrinology
while computer assisted techniques help unravel the associated genetic aspects or
the nature itself of endocrine bursts by numerical deconvolution analysis. To end the
note, attention is called to the pleiotropic characteristics of neuroendocrinology,
which keeps branching off almost endlessly as bioengineering does too.
1-Introduction
Scientific disciplines constantly evolve, usually starting at a qualitative stage (by being
mostly descriptive, as the early anatomical or zoological knowledge was), to enter later
on into more quantitative stages (like counting the number of lobes of an organ).
Obviously, some disciplines are more quantifiable and quantified than others. The car-
diovascular and respiratory systems, for example, are easier in this respect because
their variables (such as pressure and flow) have precise mathematical definitions. Psy-
chophysiology, instead, does not have yet clear-cut variables and, as a consequence, its
quantification process is slower [1]. In such line of thought, the intent here points out
to the growing quantitative and manifold characteristics of modern neuroendocrinol-
ogy, quite similar to those of bioengineering, so much, that the latter interdiscipline
now also embraces the former in many respects.
Neuroendocrinology, as a well defined but now separate area of endocrinology, is still
relatively young. Its roots can be traced back to the French scientist Claude Bernard
(1813-1878) with his studies on pancreas and also even laying the foundations for the
study of molecular signaling in endocrinology [2,3]. Bernard already appreciated the
importance of mathematics and stated that their application to natural phenom-
ena is the aim of all science; however, he also believed that many attempts were
faulty because empirical data were insufficient [4]. Charles Edouard Brown-Sequard
(1817-1894), Bernard’s student and a controversial man in some respects, was one of
the first to postulate the existence of substances, now known as hormones, secreted
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any medium, provided the original work is properly cited.into the bloodstream to affect distant organs [5]. In particular, he demonstrated
(in 1856) that removal of the adrenal glands resulted in death [6]. However, endocri-
nology’s birth certificate was issued with the demonstration by William Bayliss and
Ernest Starling, in 1902, that acid liberates a chemical messenger (secretin, a 27 amino
acid peptide) from the cells of the duodenal and jejunal mucosa and that this, via the
blood stream, excites the pancreas to secrete juices [7].
In the 1930’s, the hypothalamic control of the pituitary gland was pretty much
accepted; however, it took several years until Ernst Scharrer, in 1945, and his wife Berta
[8] showed that the preoptic region of the brain has endocrine properties associated
with pituitary function. Meanwhile, two other important and related concepts were
being developed: Walter Bradford Cannon (1871 - 1945) coining as early as 1925 the
terms fight or flight, obviously anticipatory of the stress idea, to describe an animal’s
response to threats (as body changes in pain, hunger, fear and rage), and by the introduc-
tion of another word, homeostasis, stemmed clearly in Claude Bernard’s idea of milieu
interieur (internal environment) widely popularized in his book The Wisdom of the
Body (1932). Along with this and as early as 1926, when still in his second year of medi-
cal school, Hans Selye (1907-1982) began developing his theory of the influence of stress
on a person’s ability to cope with and adapt to injury and disease. He found that patients
with a variety of ailments manifested many similar symptoms, which he ultimately
attributed to their bodies’ efforts to respond to the stresses of being ill [9-12].
Ideas, experimental data, and knowledge were quickly growing and ripening.
Towards the end of the 1950’s, Roger Guillemin (Selye’s former student) and Andrew
Schally, in their respective laboratories, were able to extract from the hypothalamus of
sheep and pigs compounds which, when administered to adenohypophyseal tissue,
brought about release of its hormones. One extract triggered the pituitary release of
ACTH (Adreno-Corticotropic Hormone), another was linked to TSH (Thyroid Stimu-
lating Hormone), still a third was stimulus for the secretion of LH (Luteinizing Hor-
mone) and a fourth was it for the secretion of FSH (Follicle Stimulating Hormone), the
latter two collectively named gonadotropic hormones. They termed these hypothalamic
substances releasing factors or releasing hormones, RF or RH, so that, for example, the
one inducing the release of TSH, was called TSH-RF or TRF. Quite significant were
the many contributions in the area; referring specifically to them exceeds the limits of
this note (see, for example, the following websites, http://www.nobelprize.org/nobel_-
prizes/medicine/laureates/1977/schally-autobio.html, or http://www.faqs.org/health/
bios/51/Roger-Guillemin.html).
A caveat that may lead to misnomering: Gonadotropic or luteotropic or any other
terms with the same endings derive their suffix tropic from Greek, trepein, “to turn
into”, as a phototropic plant, because it turns to light. Do not spell “gonadotrophic”
because trephein, also from Greek, means to feed or to nourish, giving the idea of
growth, as “hypertrophy” or its opposite “atrophy” (lack of growth).
It was not until 1969 that the nature of these hypothalamic factors would be estab-
lished. Guillemin was working with 5 million hypothalamic fragments from sheep, and
Schally with the same amount of material but from pigs. They concentrated their
efforts to the searching of one releasing factor. After a long struggle, they obtained
1 mg of a pure substance, TRF, with a single action: release of TSH from the hypophy-
sis. Soon theresafter, the structure of TRF was established (it is an extremely small
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the same year, TRF was synthesized by Guillemin’s group and two years later LH-RH
was isolated, sequenced and synthesized, another highly significant and important
quantification step, first by Schally and shortly afterwards by Guillemin. Experience in
animal research was rapidly transferred to humans and brought into clinical work. Sev-
eral new peptides were isolated from the hypothalamus, the foremost one probably
being the first inhibitor of pituitary function, somatostatin, which decreases the pro-
duction of pituitary growth hormone. In 1977, Andrew Schally and Roger Guillemin
were awarded the Nobel Prize, along with Rosalyn Sussman Yalow, for their discoveries
concerning the peptide hormone production of the brain (http://nobelprize.org/
nobel_prizes/medicine/laureates/1977/).
But what was Rosalyn’s contribution? What other factors converged to the outstand-
ing results and success? She is a physicist and mathematician, hence with a back-
ground not related to the biomedical sciences. Solomon Berson, her close collaborator,
was a physician. Getting acquainted with their lives provides surprising and touching
human insights. Radioimmunoassay (RIA), developed by them, allowed precise and
minute concentration measurements of a substance, by quantitating the binding, or the
inhibition of binding, of a radiolabeled substance to an antibody [13-15]. It was a revo-
lutionary highly quantified diagnostic process that was largely ignored when Yalow and
Berson published it in 1960. Their primary use was intended for the study of diabetes
but today its applications are multiple. Yalow and Berson (the latter died prematurely
in 1972) could have patented RIA and would have gotten enormous royalties. Instead,
to their credit, they made efforts to get RIA into common use; they wanted its poten-
tial value directed to humankind ahead of its potential value to themselves. Quite a
human lesson to underline with not too many examples to mention. Thus, neuroendo-
crinology’s final birth certificate, based on strong and well-behaved numerical grounds
and, why not, we may add with contributions from bioengineering, can be estab-
lished between the late 1950’s and early 1960’s.
The qualitative stage has been accomplished (that is, descriptions, cause-effect rela-
tionships, pathways of action, targets). Say, well established are the higher central ner-
vous system links to the adenohypophysis, in turn aimed at different targets involving
also negative regulatory feedback loops. The identified measurable variables are action
potentials at the neural side, carrying information perhaps as frequency-like modula-
tion, and exquisitely controlled concentration levels at the vascular side. Obviously,
electronic instrumentation advancements (such as microelectrode techniques brought
forward from the electrophysiology saga) played a significant role in the former. For
example, goldfish hypothalamic neuroendocrine cells have been investigated with intra-
celular recordings showing resting potentials of 50 mV and action potentials up to 117
mV followed by a long lasting and prominent diphasic hyperpolarizing after-potential.
Neuron input resistance was found in the order of 3.3 × 10
7Ω with a total time con-
stant of 42 ms [16]. No doubt, good quantitative information.
In the meantime, some people analyzed the feedback loops from the control theory
viewpoint, trying to quantify them, discussing the linear versus the non-linear
approaches and bringing about mathematical models [17,18]. But there is more recent
news, such as the hypothalamic-pituitary-thyroid axis model proposed by Liu et al,i n
1994 [19], from China, who took into account both the binding of hormones with
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Results calculated from the model were in good agreement with experimental data.
Another theoretical approach deal with prolactin rhythm in rats [20] while there is a
relatively recent more general treatment by Leng and MacGregor [21], where the
authors introduce some styles of modelling as they have been applied to neuroendo-
crine systems and discuss some of their strengths and limitations. This editorial is not
a review and, regarding this subject area, we only add that a workshop on Mathemati-
cal Neuroendocrinology was organized by the Mathematical Biosciences Institute of
Ohio State University (August 9-13, 2010; http://mbi.osu.edu/2010/mndescription.
html).
Sequencing of the human genome certainly greatly influenced the quantification pro-
cess, where computer techniques act as essential aid. Obviously, all this encompassed a
rather significant advance as concrete well-defined numbers started to enter the pic-
ture. The development of mathematical models leads to prediction, which is the high-
est level of quantification and, after all, what is a physician trying to do when he/she
examines a patient? To determine what the disease is and, above all, to predict its
most probable course. A veterinarian, an ecologist and other biologically related activ-
ities take a similar stand. In short: Scientific disciplines show a slow, sometimes faster,
but steady process of quantification. Biology, physiology and medicine are no excep-
tions. A still distant and well-yearned objective is to anticipate disease, as much in
advance and as much quantifiably as possible, based on the current known condition
of a given individual. For the time being, even with the tools nowadays at hand of the
medical profession, that prediction is still far from being exact and precise.
2-Characterization of a system
Control engineers are familiar with the convolution integral: In a linear system, know-
ing the input signal and the function describing such system, both as time dependent
events, can lead to the system’s response by convolving one with the other. A mathe-
matical operation called convolution is required. Its inverse operation is deconvolution,
i.e., knowing say the input and the output functions can produce the function that
characterizes the system. Neither of these operations is an easy task, especially the sec-
ond one. More than that, in some fields (as physiology), the explicit mathematical
functions are never known and we only have in our hands discrete experimental data
points that eventually or often do not abound. To complicate further the overall scen-
ery, linearity shows up as a big and many times highly debatable IF since most of bio-
logical processes rarely, if ever, behave in a linear way.
Notwithstanding the abovementioned difficulties, deconvolution has been used with
considerable success by Segre to characterize the dynamics of intestinal absorption as
early as 1967 [22]. Moreover, years later, several authors carried out a similar approach
to quantitatively uncover the renal retention function [23-28]. And the turn arrived in
1987 for neuroendocrinology by using a simple, ingenious and clever idea. Traditional
control engineering and the two previously referred to physiological applications of
deconvolution analysis require the injection of a known input signal, which by and
large is the impulse delta Dirac function (any other could be employed just as well, but
the delta function has some advantages). Such function, usually represented by δ(t),
was introduced by Paul Adrien Maurice Dirac (1902 - 1984), a British theoretical
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instant t. Obviously, in practice, such behavior is not truly realizable and can only be
approached by large and very short pulses. A salient highly significant feature is that
when δ(t) is applied to a linear system, the response read at its output describes the
characteristic function of the system, usually termed h(t) and called the impulse
response of the system. That is what was done when intestinal absorption and renal
function were studied, which thereafter, by proper block diagram and deconvolution
analysis led to the determination of the system’s dynamic constants [22,29].
Several neuroendocrine glands secrete their hormones as short bursts, as well
described in many papers, and such bursts can be looked at as physiological imperfect
delta functions. The brilliant concept brought forward by Veldhuis, Carlson and John-
son, in 1987 [30], simply said, no need of an external generator or injection for the sys-
tem has its own. Deconvolution did the rest and a series of superb contributions
greatly improved the quantification neuroendocrine process [31].
However, quantitative neuroendocrinology is by far much more than deconvolution.
Perhaps, Johnson and Velhuis [31] well characterized the whole intent in the preface
of their outstanding treatise, which no doubt we dare qualify as within a clear bioengi-
neering framework. Interspersed quoting from it is appropriate: “As experimental stra-
tegies have become more sophisticated, high-speed computing has been required for the
formulation and solution of more elaborate statements of neuroenocrine pulsatility,
such that matrices are needed to handle 100 to 300 equations, each containing 10 to 30
variables. Obviously, neuroendocrinology in its quantitative endeavor appears as a mul-
tidisciplinary entity with outstanding contributions from probability theory, systems
engineering, stochastic differential equations and the experimental natural sciences such
as cell and molecular biology and other approaches to subcellular analyses”. Five out of
sixteen chapters (that is, 31% of the whole book) deal with deconvolution analysis
based on the burst intrinsic glandular secretion, as the delta function simil or S(t), the
blood hormonal concentration C(t) as the output signal, and the system elimination
function E(t), as the characteristic time transference function called h(t) in systems
engineering, meaning the importance that these editors deem the subject.
3-New quantitative and pleitropic findings
The last decade (200-2010) has witnessed surprising and outstanding news that make
us wonder where the limits of neuroendocrinology really stand, something that make
us think of its pleiotropic functions or pleiotropic characteristics or, in short, the pleio-
tropism of neuroendocrinology (the term pleiotropy comes from the Greek πlεíων or
pleion, meaning “more”, and τrέπειν or trepein, meaning “to turn, to convert”; see also
the note in the first section). Thus, pleiotropic functions refer to producing more than
one effect, as a pleiotropic gene, which has multiple phenotypic expressions because it
has signaling function on various targets, because it branches off. Let us briefly review
just a few recent examples reported in the literature.
Douglas E. Brenneman, Joanna M. Hill, and Illana Gozes, in 2000 [32], referred to the
vasoactive intestinal peptide (VIP), which is a multi-functional neuropeptide with roles
that extend far beyond actions in the small intestine (where it was originally isolated).
Since its discovery in 1970, over 7000 papers have been written on VIP (as some kind of
Very Important Person, turning jokingly into a common use of the acronym), with 16%
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in the central and peripheral nervous systems. Important actions for VIP have been
reviewed for the cardiovascular, reproductive, pulmonary, immune and gastrointestinal
systems. General physiological effects include vasodilation, bronchodilation, immuno-
suppression, hormonal secretion and increases in gastric motility. However, there are
also contributions related to gene expression, receptor characterization, drug design,
functional neuroanatomy, neuroendocrine regulation, growth regulation and clinical
pathology, therapeutics and even quite attractive concepts as neurotrophism without
neurotropism, where the brain derived neurotrophic factor (BCNF) is involved (see Lu
et al) [33], the latter authors from San Diego, La Jolla, CA.
Galanin-like peptide (GALP) is a newly discovered hypothalamic neuropeptide, which
is regulated by leptin and implicated in the regulation of GnRH (Gonadotropin-releasing
hormone, also known as Luteinizing-Hormone-Releasing Hormone or LHRH), the latter
responsible for the release of FSH and LH from the anterior pituitary. After searching
the human genome database it was determined that the human GALP gene comprises
six exons. Mature GALP is predicted to be 60 amino acids in the macaque as in other
species. Besides, the distribution of GALP mRNA in the hypothalamus and pituitary of
the macaque showed that, as in rodent species, the expression of GALP mRNA is con-
fined to the arcuate nucleus, median eminence, and neurohypophysis [34].
Matthias Tschöp and Tamas L. Horvath [35] commented the increasingly sophisti-
cated methods that have been brought to bear on the problem of the brain involve-
ment in the physiology of energy homeostasis and the pathogenesis of obesity. A vast
number of experimental observations have been produced. The combination of genetic
and sophisticated physiology techniques has allowed for great progress. These methods
helped the identification of metabolic hormones and their relationship to key peptider-
gic systems in the hypothalamus. Furthermore, researchers are far from yet under-
standing the overall picture of central body weight regulation that involves multiple
brain areas outside the hypothalamus.
Brighton, Szekeres and Willars [36] studied Neuromedin U (NmU). It is a structu-
rally highly conserved neuropeptide. It is ubiquitously distributed, with highest levels
found in the gastrointestinal tract and pituitary. Originally isolated from porcine spinal
cord, it has since been isolated and sequenced from several species. Amino acid align-
ment of NmU from different species reveals a high level of conservation, and particular
features within its structure are important for bioactivity. The conservation of NmU
across a wide range of species indicates a strong evolutionary pressure to conserve this
peptide and points to its physiological significance. NmU was first isolated based on its
ability to contract rat uterine smooth-muscle (hence the suffix “U”) and has since been
implicated in the regulation of smooth-muscle contraction, blood pressure and local
blood flow, ion transport in the gut, stress responses, cancer, gastric acid secretion,
pronociception, and feeding behavior.
Ying Yang, Li-bin Zhou et al [37] investigated the expression of feeding-related pep-
tide receptors mRNA in GT1-7 cell line and roles of leptin and orexins in the control
of GnRH secretion. It was concluded that feeding and reproductive functions are clo-
sely linked. Many orexigenic and anorexigenic signals may control feeding behavior as
well as alter GnRH secretion through their receptors on GnRH neurons.
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of islet hormone secretion, as well as hepatic and gastric function. Because GLP-1 is
also synthesized in the brain, where it regulates food intake, it is hypothesized that the
central GLP-1 system regulates glucose tolerance as well, are concepts put forward by
Sandoval et al and Lauffer et al [38,39].
4-Conclusions
All these contributions brought quantification to neuroendocrinology, and this is pre-
cisely one of the general objectives of bioengineering (or biomedical engineering): to
bring quantification into the biological sciences or at least to show pathways leading to
it. Experimental methods and techniques encompass one of the earliest and most
obvious ways, but uncovering a possible mathematical description, especially when
feedback and feedforward loops are quantitatively included (as for example the feed-
back constant, often called b in the engineering jargon) represents a quantitative step
forward. Disclosing the molecular structure of a hormone, with its molecular weight
and other related parameters, its affinity with other biochemical structures (as radicals
may be), identification of receptor sites, gene expression, and the like are other quanti-
fying forms. Most important and not fully known yet appear the transduction mechan-
isms linking neural action potentials, -modulated in frequency or in some form of
pulse position-like modulation to carry on stimulating or inhibiting information- to
actual secretory gland activity measured in micro or nanograms per unit time, which
in the end will mean hormonal concentrati o ni nb l o o de x p r e s s e di nm a s su n i t sp e r
milliliter. Do we have an efficiency factor for those transducers, that is, a parameter
saying that so many action potentials are required to secrete so many nanograms of
hormone in one second? Predictive mathematical models are still quite ahead in our
dreams although some pathways are being opened while a technological demand unit
instructing the gland to increase or decrease its amount of secretion does not appear
as too far fetched. No doubt, neuroendocrinology entangles with and forms part of
bioengineering while the Seven Lamps of the latter keep spreading their lights [40].
Note
To measure is to know, if you can not measure it, you can not improve it; after all,
there is no real satisfaction in formulas alone unless you can feel their numerical mag-
nitude. Sir William Thomson, Lord Kelvin (1824-1907), British Physicist and
Mathematician
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